Estados financieros detallados de Prelude Therapeutics Incorporated (PRLD): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 98.3%, margen operativo -300.6%, margen neto -269.7%.
Al precio actual de $4.47, PRLD presenta beneficios negativos (P/E no significativo) y un ROE del -75.35%. La capitalización bursátil es de $254M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | $7.0M | $12.1M |
| Coste de Ventas | $149000 | 0 | 0 | 0 | 0 | 0 | 0 | $1.7M |
| Beneficio Bruto | -$149000 | 0 | 0 | 0 | 0 | 0 | $7.0M | $10.4M |
| I+D | $12.6M | $24.3M | $48.2M | $86.8M | $92.9M | $103.4M | $118.0M | $94.3M |
| Generales y Administrativos | $2.4M | $3.8M | $10.6M | $27.0M | $30.7M | $28.9M | $28.7M | $22.4M |
| Gastos Operativos | $15.0M | $28.1M | $58.8M | $113.7M | $123.5M | $132.3M | $146.7M | $115.0M |
| Beneficio Operativo | -$15.0M | -$28.1M | -$58.8M | -$113.7M | -$123.5M | -$132.3M | -$139.7M | -$104.6M |
| EBITDA | -$14.8M | -$27.7M | -$58.2M | -$110.8M | -$114.1M | -$120.7M | -$125.4M | -$97.8M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$14.7M | -$27.6M | -$56.9M | -$111.7M | -$115.4M | -$121.8M | -$127.2M | -$99.5M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$14.7M | -$27.6M | -$56.9M | -$111.7M | -$115.4M | -$121.8M | -$127.2M | -$99.5M |
| BPA | $-9.31 | $-0.85 | $-1.30 | $-2.33 | $-2.27 | $-2.02 | $-1.68 | $-1.29 |
| BPA Diluido | $-9.31 | $-0.85 | $-1.30 | $-2.33 | $-2.27 | $-2.02 | $-1.68 | $-1.29 |
| Acciones en Circulación (Diluidas) | $1.6M | $32.4M | $43.7M | $47.6M | $47.4M | $60.4M | $75.8M | $77.0M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $6.5M | $5.6M | $4.6M | $5.7M |
| Beneficio Bruto | $6.5M | $5.6M | $4.2M | $5.7M |
| Beneficio Operativo | -$20.4M | -$17.3M | -$14.2M | -$15.5M |
| EBITDA | -$19.3M | -$16.0M | -$10.0M | -$13.6M |
| Beneficio Neto | -$19.7M | -$16.5M | -$10.4M | -$13.9M |
| BPA | $-0.26 | $-0.26 | $-0.13 | $-0.14 |
| BPA Diluido | $-0.26 | $-0.26 | $-0.13 | $-0.14 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $15.6M | $18.9M | $218.3M | $31.8M | $30.6M | $25.3M | $12.5M | $35.3M |
| Inversiones a Corto | 0 | 0 | 0 | $259.4M | $171.1M | $207.6M | $121.1M | $68.0M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $15.6M | $20.2M | $220.8M | $295.1M | $204.4M | $235.6M | $135.9M | $105.7M |
| Inmovilizado Material | $811000 | $1.6M | $2.5M | $5.6M | $6.7M | $37.7M | $35.5M | $32.3M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $16.4M | $21.9M | $223.6M | $305.1M | $220.5M | $277.7M | $175.5M | $141.3M |
| Cuentas por Pagar | $1.4M | $2.0M | $3.9M | $7.8M | $6.8M | $4.6M | $7.7M | $4.0M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.4M | $4.8M | $11.4M | $19.2M | $21.7M | $21.8M | $25.6M | $53.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $39.1M | $71.3M | $11.4M | $19.2M | $25.1M | $40.6M | $44.1M | $72.7M |
| Reservas | -$22.9M | -$50.5M | -$107.4M | -$219.1M | -$334.6M | -$456.4M | -$583.6M | -$683.1M |
| Patrimonio Neto | -$22.7M | -$49.4M | $212.2M | $285.9M | $195.4M | $237.1M | $131.5M | $68.6M |
| Deuda Total | 0 | $258000 | 0 | $1.7M | $1.8M | $16.9M | $18.0M | $17.8M |
| Deuda Neta | -$15.6M | -$18.6M | -$218.3M | -$289.5M | -$199.9M | -$216.0M | -$115.6M | -$85.4M |
| Capital Circulante | $13.1M | $15.4M | $209.4M | $275.9M | $182.7M | $213.8M | $110.3M | $52.7M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $47.5M | $35.3M | $21.8M | $26.3M |
| Activos Totales | $94.8M | $141.3M | $119.6M | $189.4M |
| Pasivos Totales | $36.2M | $72.7M | $59.5M | $55.6M |
| Patrimonio Neto | $58.5M | $68.6M | $60.2M | $133.7M |
| Deuda Total | $17.9M | $17.8M | $17.7M | $17.6M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$14.7M | -$27.6M | -$56.9M | -$111.7M | -$115.4M | -$121.8M | -$127.2M | -$99.5M |
| Amortizaciones | $149000 | $382000 | $542000 | $915000 | $1.3M | $1.2M | $1.8M | $1.3M |
| Compensación en Acciones | $180000 | $846000 | $5.6M | $20.9M | $25.1M | $25.6M | $21.3M | $11.9M |
| Cambio en Capital Circulante | $1.4M | $667000 | $4.6M | $3.6M | $932000 | -$10.5M | $4.2M | $28.4M |
| Flujo de Caja Operativo | -$13.0M | -$25.7M | -$46.2M | -$83.5M | -$83.7M | -$107.1M | -$102.9M | -$56.3M |
| Inversiones (CapEx) | -$529000 | -$780000 | -$621000 | -$2.3M | -$3.0M | -$3.5M | -$764000 | -$67000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$13.5M | -$26.4M | -$46.8M | -$85.9M | -$86.7M | -$110.6M | -$103.7M | -$56.4M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$19.1M | $23.1M | -$21.7M | -$15.6M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$19.1M | $23.1M | -$21.7M | -$15.6M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $2.4M | $1.8M | $2.0M | $2.0M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | | | | | +73.4% |
| Crecimiento Beneficio Neto (anual) | | -87.8% | -106.5% | -96.2% | -3.4% | -5.5% | -4.4% | +21.8% |
| Crecimiento BPA (anual) | | +90.9% | -52.9% | -79.2% | +2.6% | +11.0% | +16.8% | +23.2% |
| Cambio en Acciones (anual) | | +1955.4% | +34.9% | +8.9% | -0.5% | +27.4% | +25.6% | +1.5% |
| Crecimiento FCF (anual) | | -96.1% | -77.0% | -83.5% | -1.0% | -27.5% | +6.3% | +45.6% |
| Margen Bruto | | | | | | | 100.0% | 85.9% |
| Margen Operativo | | | | | | | -1995.9% | -861.3% |
| Margen EBITDA | | | | | | | -1791.4% | -805.5% |
| Margen Neto | | | | | | | -1816.8% | -819.6% |
| Margen FCF | | | | | | | -1480.7% | -464.3% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-8.55 | $-0.82 | $-1.07 | $-1.80 | $-1.83 | $-1.83 | $-1.37 | $-0.73 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.6M | $32.4M | $43.7M | $47.6M | $47.4M | $60.4M | $75.8M | $77.0M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -75.35% |
| Rentabilidad sobre capital invertido | -43.74% |
| Rentabilidad sobre activos | -31.94% |
| Margen bruto | 98.26% |
| Margen operativo | -300.56% |
| Margen neto | -269.75% |
Salud financiera
| Deuda / Patrimonio | 0.13 |
| Ratio corriente | 4.07 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -7.34 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -2.81 | -30.82 | -55.04 | -5.34 | -2.66 | -2.11 | -0.76 | -2.25 |
| P/VC | -1.82 | -17.18 | 14.74 | 2.07 | 1.46 | 1.09 | 0.73 | 3.25 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.75 | 18.38 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 85.9% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -1995.9% | -861.3% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -1816.8% | -819.6% |